ExactAb™,低内毒素,已验证,无动物源,无叠氮钠,无载体,重组 级 提供 ≥95%(SDS-PAGE&SEC-HPLC) 纯度，适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存,避免反复冻融。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Panitumumab (anti-EGFR) 是一种全人源IgG2抗EGFR单克隆抗体，具有抗肿瘤活性。Panitumumab (anti-EGFR) 抑制肿瘤细胞增殖、存活和血管生成。Panitumumab (anti-EGFR) 可用于癌症研究，例如结肠癌。
Panitumumab (anti-EGFR) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab (anti-EGFR) inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab (anti-EGFR) can be used in the research of cancers, such as colon cancer.
Panitumumab (anti-EGFR) (Ab169317) - Flow Cytometry
Flow Cytometry analysis of A431 cells labelling EGFR (red) with Panitumumab (anti-EGFR) (Ab169317). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Panitumumab (anti-EGFR) (Ab169317) - SEC
The purity of Panitumumab (anti-EGFR) (Ab169317) is more than 95% verified by HPLC.
Panitumumab (anti-EGFR) (Ab169317) - ELISA
Immobilized EGFR at 2 μg/mL can bind Panitumumab (anti-EGFR) (Ab169317) with the EC50 of 47.19 ng/mL.
Panitumumab (anti-EGFR) (Ab169317) - ELISA
Immobilized Recombinant Human EGFR protein (rp176273) at 1.0 μg/mL can bind Panitumumab (anti-EGFR) (Ab169317) with the EC50 of 23.66 ng/mL.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
 ZJ25F0927184 |
分析证书 | Ab169317 |
| ZJ25F0927183 |
分析证书 | Ab169317 |
| ZJ25F0116933 |
分析证书 | Ab169317 |
| ZJ23F0901037 |
分析证书 | Ab169317 |
| ZJ23F0901035 |
分析证书 | Ab169317 |
我们的级别选择指南涵盖了目录中所有的变体的纯度、稳定剂状态和应用适用性。
查看 Animal Free 级别指南 → 查看 Carrier Free 级别指南 → 查看 Recombinant 级别指南 → 查看 Validated 级别指南 → 查看 ExactAb™ 级别指南 → 查看 Low Endotoxin 级别指南 → 查看 Azide Free 级别指南 →
危险品化学品经营许可证（带存储）